Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

9 results about "Microarray" patented technology

A microarray is a multiplex lab-on-a-chip. It is a two-dimensional array on a solid substrate (usually a glass slide or silicon thin-film cell) that assays (tests) large amounts of biological material using high-throughput screening miniaturized, multiplexed and parallel processing and detection methods. The concept and methodology of microarrays was first introduced and illustrated in antibody microarrays (also referred to as antibody matrix) by Tse Wen Chang in 1983 in a scientific publication and a series of patents. The "gene chip" industry started to grow significantly after the 1995 Science Paper by the Ron Davis and Pat Brown labs at Stanford University. With the establishment of companies, such as Affymetrix, Agilent, Applied Microarrays, Arrayjet, Illumina, and others, the technology of DNA microarrays has become the most sophisticated and the most widely used, while the use of protein, peptide and carbohydrate microarrays is expanding.

Compound biochip based on photon crystal

InactiveCN101358242AImprove performanceEnhanced signal selectivityMicrobiological testing/measurementMicrosphereComposite substrate
A making method of a composite type biological chip based on a photonic crystal comprises four steps which are preparation of hard substrates, preparation of photonic crystal thin membranes, connection of membranous substrates and surface treatment of the substrates. (1) the preparation of hard substrates: common hard substrates are cleaned by soapy water, washed by de-ionized water and dried, and amino-group or hydroxyl is decorated on the surfaces of the substrates; (2) the preparation of photonic crystal: the nano-microspheres such as specific monodisperse silicon dioxide or polystyrene and the like, which are different in size according to the positions of testing signals, are assembled on the surfaces of the treated substrates to form the photonic crystal thin membrane with the thickness of 20 to 30 microns (3) the connection of membranous substrates: the surface of the photonic crystal thin membrane is laid with a layer of the membranous substrate and the connection is fixed by utilizing the chemisorption or the mutual function between positive and negative charges; (4) the surface treatment of the substrates: by using the methods such chemisorption and the like, chemical groups which can be fixedly connected with biomolecules to be tested are decorated on the membranous layer parts of the surfaces of the composite substrates which are formed in the step (3).
Owner:SOUTHEAST UNIV

Identification of silkworm hemocyte specific expressed gene cathepsin O regulation element

PendingCN104894231AMicrobiological testing/measurementFermentationCathepsin OScreening method
The invention relates to a screening method of silkworm hemocyte specific expressed genes and a method for analyzing and finding a hemocyte specific expression regulation element through cloning of a protease O gene promoter. The hemocyte specific expression regulation element is manufactured through the following steps that 1, a hemocyte specific expression candidate gene protease O gene is screened out through silkworm tissue chip expression data, transcriptome data, a quantitive RT-PCR and other methods, and the silkworm hemocyte specific expression of the gene is verified successfully; 2, a related gene promoter is successfully cloned, and functional analysis is carried out; 3, a Bac-to-Bac rhabdovirus expression system is successfully improved, an effective hemocyte promoter detection system is built, the activity of the candidate gene promoter is detected at the cell and the individual level, and tissue specificity of the promoter is verified; 4, the silkworm hemocyte specific gene protease O gene promoter is obtained through the study, and it is analyzed and found that the promoter is provided with the tissue specificity regulation element in the section between the upstream -333 and -80 of a transcriptional start site. The specificity expression of the gene on hemocyte is controlled.
Owner:SOUTHWEST UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products